




































Microbiological Research 179 (2015) 45–53
Contents lists available at ScienceDirect
Microbiological  Research
j ourna l h om epage: www.elsev ier .com/ locate /micres
xpression  of  bacteriocin  LsbB  is  dependent  on  a  transcription
erminator
ordana  Uzelaca,d,1, Marija  Miljkovica,1,  Jelena  Lozoa,c, Zorica  Radulovicd, Natasa  Tosicb,
ilan  Kojica,∗
Laboratory for Molecular Microbiology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
Faculty of Biology, University of Belgrade, Serbia
Faculty of Agriculture, University of Belgrade, Serbia
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 22 February 2015
eceived in revised form 28 June 2015
ccepted 28 June 2015
vailable online 16 July 2015
a  b  s  t  r  a  c  t
The  production  of  LsbB,  leaderless  class  II bacteriocin,  is encoded  by  genes  (lsbB  and  lmrB)  located  on
plasmid  pMN5  in  Lactococcus  lactis  BGMN1-5.  Heterologous  expression  of  the  lsbB  gene using the  pAZIL
vector  (pAZIL-lsbB)  in  L.  lactis subsp.  cremoris  MG7284  resulted  in  a significant  reduction  (more  than  30
times)  of bacteriocin  LsbB  expression.  Subcloning  and  deletion  experiments  with  plasmid  pMN5  revealed




stream  of  the  lsbB  gene.  RNA  stability  analysis  revealed  that the  presence  of  a  transcription  terminator
increased  the  RNA  stability  by  three  times  and  the  expression  of  LsbB  by  30  times.  The  study  of the
influence of  transcription  terminator  on  the  expression  of  other  bacteriocin  genes (lcnB,  for  lactococcin  B
production)  indicated  that  this  translational  terminator  likely  functions  in a lsbB-specific  manner  rather
than  in  a  general  manner.
© 2015  Elsevier  GmbH.  All  rights  reserved.. Introduction
Bacteriocins are ribosomally synthesized antimicrobial peptides
roduced by bacteria. Bacteriocins have been the focus of consid-
rable scientific interest for years, but they are relatively under-
tilized by the food, veterinary and medical industries. To fully
ealize the potential of bacteriocins, it is necessary to understand
he biology of bacteriocins, their structure–function relationships,
he regulation of gene expression, and their mode of action. The
xpression of genes involved in bacteriocin production is usu-
lly controlled by a quorum sensing system (Kleerebezem et al.
997; Nes and Eijsink 1999). All quorum sensing systems utilize
mall, secreted signaling molecules known as autoinducers, which
elong to one of the following three categories: acylatedhomoser-
ne lactones (AHLs) used by Gram-negative bacteria, peptide signals
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944-5013/© 2015 Elsevier GmbH. All rights reserved.used by Gram-positive bacteria and autoinducer-2 (AI-2) used by
both types of bacteria (La Sarre and Federle 2013). In many Gram-
positive bacteria, production of bacteriocins is inducible and induc-
tion requires secretion and extracellular accumulation of peptides
that act as chemical messengers that trigger bacteriocin production.
These inducer peptides are often referred to as autoinducers and are
believed to permit a quorum sensing-based regulation of bacterio-
cin production. Notably, some peptides that act as autoinducers
also have antimicrobial activity, and some bacteriocins act as their
own autoinducers. The autoinducer-dependent induction of bac-
teriocin production requires histidine protein kinases and response
regulator proteins for two-component signal transduction systems.
The other component of this system is a cognate response regu-
lator that promotes transcription of the regulated promoters and
which is activated by the pheromone-activated kinase (Risøen et al.
2000; Eijsink et al. 2002). Class IIa bacteriocins require at least
four genes including structural, immunity, ABC transporter and
accessory protein genes (Fimland et al. 2005). Some members of
class IIa bacteriocins (curvacin A, sakacin P, carnobacteriocin B2,
enterocin A, Kleerebezem and Quadri 2001), and some class IIb bac-
teriocins (ABP-118, plantaricin E/F, plantaricin J/K9, Anderssen et al.
1998; Flynn et al. 2002) are transcriptionally regulated through
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eptide involved in the production of class II bacteriocins is usually
 non-modified short peptide with no or very limited antimicro-
ial activity. In the case of nisin (class I), the bacteriocin itself
cts as a pheromone, which activates a “two-component” regu-
atory system. In this case, nisin induces the expression of genes
hat are necessary for its own production. The genes and pro-
oters involved in nisin production have been used to develop
 nisin-controlled expression (NICE) system. Several nis-promoter
ectors were constructed that are suitable for tightly controlled
xpression of heterologous proteins in lactococci (De Ruyter et al.
996), lactobacilli (Pavan et al. 2000), and other Gram-positive
acteria (Eichenbaum et al. 1998), which is a great biotechno-
ogical success. Similar systems may  be developed on the basis
f genes and promoters involved in the production of class II
acteriocins.
Our previous studies on the expression of LsbB showed that
he highest production level was obtained by the Lactococcus lactis
GMN1-596T strain, harboring the whole operon that is natu-
ally involved in LsbB production in a natural organization (pMN5
lasmid, Gajic et al. 2003; Kojic et al. 2006). LsbB, a class IId bac-
eriocin, is a relatively hydrophilic protein synthesized without
n N-terminal leader sequence or signal peptide. It is transported
y LmrB, which at the same time acts as an immunity protein.
ecently, it has been shown that Zn-dependent metallopeptidase is
esponsible for sensitivity to LsbB (Uzelac et al. 2013), representing
he most likely receptor protein. Furthermore, structure–function
nalyses provide strong evidence that the receptor-binding part of
sbB is located in the C-terminal domain (Ovchinnikov et al. 2014).
revious experiments have shown that the strain MG7284/pAZIL-
sbB carrying lsbB cloned with its own promoter (PlsbB) expresses
 lower zone of inhibition on the sensitive strain BGMN1-596 than
he strain BGMN1-596T, indicating the involvement of additional
equences or genes in the increased bacteriocin activity of L. lactis
GMN1-596T. In the present work the regulation of LsbB expression
as analyzed, indicating that the region responsible for regula-
ion is located within 60 nucleotides immediately downstream of
he lsbB gene on the pMN5 plasmid. Until now, the mechanism
or regulation could not be confirmed. The most likely factor was
hought to be the stability of messenger RNA, whether the regula-
ion occurs at the transcriptional or translational level. It has been
roven, however, that the downstream region including a tran-
cription terminator is responsible for increased expression of LsbB
acteriocin.
. Materials and methods
.1. Bacterial strains, plasmids, and growth conditions
The strains, their derivatives and plasmids used in this study
re listed in Table 1. L. lactis strains were grown in M17 medium
Merck GmbH, Darmstadt, Germany) supplemented with 0.5% glu-
ose (GM17) at 30 ◦C. Escherichia coli strains were grown in Luria
ertani broth (LB) at 37 ◦C with aeration. To each medium, agar
1.5%; Torlak, Belgrade, Serbia) was added for use as a solid medium.
ll strains carrying constructs were stored in a growth medium con-
aining 15% glycerol (Sigma Chemie GmbH, Deisenhofen, Germany)
t −80 ◦C. The following antibiotic concentrations (in g/mL) were
sed: erythromycin, 10 (lactococci) and 300 (E. coli); chloram-
henicol, 10 (lactococci) and 30 (E. coli); and ampicillin, 100
E. coli). 5-Bromo-4-chloro-3-indolyl--d-galactoside (X-Gal) (Fer-entas, Vilnius, Lithuania) was added to LB medium plates for
lue/white color selection of colonies at a final concentration
f 20 g/mL (E. coli) and 80 g/mL (L. lactis construct with lacZ
usion). Ortho-nitrophenyl--galactoside (ONPG) was used for the
-galactosidase assay (Sigma Chemical Co. St. Louis, MO).esearch 179 (2015) 45–53
2.2. Bacteriocin detection and activity assay
For detection of bacteriocin activity, an agar-well diffusion assay
was performed as described previously by Lozo et al. (2004). For
testing the level of LsbB production serial double dilutions of fil-
tered supernatants (16 h old culture) of the different producers and
synthetic LsbB were spotted (5 L) on the surface of the top agar
inoculated with BGMN1-596. Zones of inhibition were compared
by size and intensity with zones formed by synthetic LsbB (known
concentrations; ChinaPeptides Co., Ltd.; Uzelac et al. 2013) in order
to quantify production by different producers.
2.3. DNA manipulations
Plasmids from lactococci were isolated by modification of the
method described by O’Sullivan and Klaenhammer (1993). For plas-
mid  isolation from E. coli a Thermo Scientific GeneJET Plasmid
Miniprep kit was used according to the manufacturer’s recommen-
dations (Thermo Scientific, Lithuania). Digestion with restriction
enzymes was conducted according to the supplier’s instructions
(Fermentas, Lithuania). Lactococci were transformed with plas-
mid  constructs using a Gene Pulser Eporator (Eppendorf, Hamburg,
Germany) as described previously (Holo and Nes 1989). Standard
heat-shock transformation was  used for plasmid transformation
of E. coli (Hanahan 1983). The DNA fragments from agarose gels
were purified using a Thermo Scientific GeneJET Gel Extraction kit
as described by the manufacturer (Thermo Scientific, Lithuania).
DNA was ligated with T4 DNA ligase (Agilent technologies, USA)
according to the manufacturer’s recommendations. Sets of specific
primers used in this study are listed in Table 2. Total RNA was
isolated from derivatives MG7284/pAZIL-EX and MG7284/pAZIL-
lsbB by an SV Total RNA Isolation system (Promega, Madison, USA).
Thermo Scientific Random hexamer, RiboLockRNAse Inhibitor and
RevertAid Reverse Transcriptase were used to generate comple-
mentary DNA (cDNA) from the RNA template by RT-PCR. KapaTaq
DNA Polymerase (Kapa Biosystems, Inc., Boston, MA,  USA) was  used
to amplify DNA fragments using a GeneAmp PCR System 2700
thermal cycler (Applied Biosystems, Foster City, CA, USA). PCR prod-
ucts were purified with a Thermo Scientific PCR Purification Kit
according to the manufacturer’s protocol and sequenced by the
Macrogen Sequencing Service (Macrogen, The Netherlands). The
sequences were analyzed in the NCBI database using BLAST. Com-
mercial p-GEM-T-Easy (Promega, Madison, USA) or pBluescriptT/A
vectors were used for cloning of PCR products. The pBluescriptT/A
vector was constructed using synthesized pBS-T/A oligonucleotide
(Table 2) and BamHI digested pBluescript. First, pBS-T/A oligonu-
cleotide (designed to provide 12 amino acid in frame with lacZ
carrying the following restriction sites NdeI, XcmI, NcoI, SphI, NcoI,
XcmI and NdeI) was  self-annealed to leave BamHI cohesive ends and
then ligated with predigested pBluescript with BamHI. The pBlue-
scriptT/A vector was designed for efficient direct cloning of PCR
products. It contains two  XcmI restriction sites oriented towards
each other that generate 3′ thymine single nucleotide overhangs
on both 3′-ends after digestion. It also contains NcoI and SphI
restriction sites for destruction of an internal fragment (XcmI-NcoI-
SphI-NcoI-XcmI) in order to prevent its re-ligation into the vector
and BamHI for testing and blue-white screening of cloned frag-
ments. Efficiency of the constructed pBluescriptT/A vector to accept
PCR fragments was  tested in DH5 and it was found that more than
95% of the transformants contain the correct insert.
2.4. Gene knock-outThe construct pAZIL-EX was  used for gene knock-out exper-
iments. To knock out lsbB, pAZIL-EX was  digested with the NcoI
restriction enzyme and then blunted using Klenow enzyme
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Table  1
Bacterial strains and plasmids used in this study.
Strain or plasmids Relevant characteristics Source or reference
L. lactis subsp. lactis
IL1403 Plasmid free derivative of IL596 Chopin et al. (1984)
BGMN1-596 Plasmid free derivative of L. lactis subsp. lactis BGMN1-5 Gajic et al. (1999)
BGMN1-596T Derivative of BGMN1-596 with pMN5 plasmid Gajic et al. (1999)
BGMN1-501 Plasmid cured derivative of L. lactis subsp. lactis BGMN1-5, LcnB producer Kojic et al. (2006)
B464 ptn deletion mutant of IL1403 Diep et al. (2007)
B464/pAZIL-LcnB Derivative of IL1403 with pAZIL-LcnB This study
B464/pAZIL-LcnBTT Derivative of IL1403 with pAZIL-LcnBTT This study
L.  lactis subsp. cremoris
MG7284 Prt− , Lac− , Bacs, MG1363 Fusr, Spcr Gasson (1983)
MG7284/pAZIL-lsbB Derivative of MG7284 with pAZIL-lsbB Uzelac et al. (2013)
MG7284/pAZIL-EX Derivative of MG7284 with pAZIL-EX This study
MG7284/pNZ8150-lsbB Derivative of MG7284 with pNZ8150-lsbB This study
E.  coli
DH5 supE44 lacU169 (ø80 lacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Hanahan (1983)
EC101 JM101 containing repA gene of pWV01 in chromosome Law et al. (1995)
Plasmids
pMN5 Natural plasmid carrying lsbB operon Kojic et al. (2006)
pAZIL 7109 bp, Emr, shuttle cloning vector Kojic et al. (2011)
pAZIL-EX pAZIL carrying EcoRI-XmnI fragment of pMN5 (2821 bp) This study
pAZIL-bN pAZIL-EX with lsbB gene knock-out in NcoI restriction site This study
pAZIL-NSS  pAZIL-EX with lsbB and lmrB genes deletant (NcoI- ScaI- ScaI fragments) This study
pAZIL-SS  pAZIL-EX with lmrB gene deletant of ScaI fragment This study
pAZIL-ES pAZIL carrying EcoRI-ScaI  fragment of pMN5 (736 bp) This study
pAZIL-PlsbB pAZIL carrying PlsbB promoter This study
pAZIL-PlsbB-lsbB pAZIL carrying lsbB gene under PlsbB promoter This study
pAZIL-PlsbB-lsbA pAZIL carrying lsbA gene under PlsbB promoter This study
pAZIL-PlsbB-lsbX pAZIL carrying lsbX gene under PlsbB promoter This study
pAZIL-PlsbB-lsbY pAZIL carrying lsbY gene under PlsbB promoter This study
pAZIL-PlsbB-lsbXY pAZIL carrying lsbXY genes under PlsbB promoter This study
pAZIL-PlsbB-lsbZ pAZIL carrying lsbZ gene under PlsbB promoter This study
pAZIL-lsbB pAZIL carrying lsbB This study
pAZIL-lsbBlsbX pAZIL carrying lsbB and lsbX genes This study
pAZIL-lsbBlsbXY pAZIL carrying lsbB, lsbX and lsbY genes This study
pAZIL-lsbBlsbX1 pAZIL carrying lsbB and lsbX genes with deletion of last 5 nucleotides of lsbX gene This study
pAZIL-lsbBlsbX2 pAZIL carrying lsbB and lsbX genes with deletion of last 12 nucleotides of lsbX gene This study
pAZIL-lsbBlsbX3 pAZIL carrying lsbB and lsbX genes with deletion of last 22 nucleotides of lsbX gene This study
pAZIL-lsbBlsbX4 pAZIL carrying lsbB and lsbX genes with deletion of last 38 nucleotides of lsbX gene This study
pAZIL-lsbBlsbXSt pAZIL carrying lsbB and lsbX genes with inserted stop codon into lsbX gene This study
pAZIL-lsbBEV pAZIL carrying lsbB gene and five nucleotides downstream of lsbB gene This study
pNZ8150 Cmr, NICE expression vector Mierau and Kleerebezem (2005)
pNZ8150-lsbB pNZ8150 carrying lsbB gene This study
pBluescript 2958 bp, Ampr, cloning vector Stratagene
pBluescriptT/A 2994 bp, Ampr, PCR cloning vector This study
pNZ8150-lacZ1 pNZ8150 carrying lacZ1 gene This study
pNZ8150-PlsbB-lacZ pNZ8150 carrying PlsbB and lacZ gene This study
p-GEM-T-Easy 3015 bp, Ampr, PCR cloning vector Promega

















pBSLcnBTT pBSTT carrying lcnB gene as SalI-ClaI fragm
pAZIL-LcnB pAZIL vector carrying lcnB gene 
pAZIL-LcnBTT pAZIL vector carrying lcnB gene and transcr
insertion of four nucleotides; construct pAZIL-bN). Knocking out
he lsbB and lmrB genes was performed by their deletion from
AZIL-EX by digestion with NcoI/ScaI. The obtained construct
as circularized by ligase enzyme after treatment with Klenow
nzyme and used for transformation of E. coli DH5 (construct
AZIL-NSS). Knocking out lmrB was performed by its deletion
rom pAZIL-EX by digestion with the ScaI  enzyme. The mixture
as ligated and used for transformation of E. coli DH5 (con-
truct pAZIL-SS). Lactococci strains MG7284 and IL1403 were
ransformed with the constructs (pAZIL-bN, pAZIL-NSS and
AZIL-SS) and bacteriocin activity was tested.
.5. Expression of target genes under the PlsbB promoterThe LsbB promoter, PlsbB, was amplified by PCR using primers
lsbBEcoRIF and PlsbBBamHIR (Table 2), where pAZIL-EX was
sed as template. The obtained fragment was cloned into theThis study
This study
 terminator This study
commercial pGEM-T-Easy vector, and then recloned into the pAZIL
vector as a fragment EcoRI/BamHI (the primers contain these
restriction sites in order to obtain the correct orientation). The
designed construct, pAZIL-PlsbB, was  used for further experiments.
Likewise, the genes lsbA, lsbX, lsbY, lsbZ and lsbXY, were amplified
from pAZIL-EX using the appropriate primers (Table 2) and cloned
into the commercial pGEM-T-Easy vector. The fragments were
transferred into the pAZIL-PlsbB vector as BamHI/PstI,  downstream
of the PlsbB promoter. L. lactis MG7284 was  transformed with
each of the constructs, and the obtained derivatives were used as
bacteriocin producers in the agar well diffusion assay.
2.6. Promoter cloning and LacZ fusionFor analysis of the lsbB promoter activity, PlsbB was fused
to the lacZ gene. The PlsbB promoter transcriptional fusion was
constructed as follows; the amplified and cloned promoter PlsbB
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Table 2
Sequence of specific primers used in this study.










RT1  5′-TCTATGCTCCAAAAAGCGCT-3′ cDNK MG7284/pAZIL-EX,
cDNK BGMN1-596T
RT2  5′-GGATATTTAAAATGATAATTGTAGG-3′ cDNK MG7284/pAZIL-EX,
cDNK BGMN1-596T
RT3  5′-TGACTAATCAATATGTTCC-3′ cDNK MG7284/pAZIL-EX,
cDNK BGMN1-596T
RT4  5′-TGTATCTTGATAGAAAGGAAG-3′ cDNK MG7284/pAZIL-EX,
cDNK BGMN1-596T
rpoBsalcod F 5′-TGTATCTTGATAGAAAGGAAG-3′ cDNK MG7284/pAZIL-lsbB,
cDNK MG7284/pAZIL-lsbB
cDNK MG7284/pAZIL-ES
rpoBsalcod R 5′-TGTATCTTGATAGAAAGGAAG-3′ cDNK MG7284/pAZIL-lsbB
cDNK MG7284/pAZIL-ES







LcnBF  5′-GAAAACTTATTTCAATTAC-3′ BGMN501
LcnBR  5′-ATCGATTAGTGGAATGTTTTTCCCCATCC-3′ BGMN501






























concentration in cultures was 2 g/mL. Cultures were grown tontroduced restriction sites are indicated by underlined sequences
as transferred from pGEM-T-Easy (pGEM-T-PlsbB) as an EcoRI-
amHI fragment to pNZ8150-lacZ1 (Vukotic et al. 2015). The
igation mixture was used to transform E. coli EC101. The con-
truct, designated pNZ8150-PlsbB-lacZ1, was used for further
xperiments. L. lactis MG7284 was transformed with construct
NZ8150-PlsbB-lacZ, resulting in the strain MG7284/pNZ8150-
lsbB-lacZ1, which was used for additional transformation with
onstructs pAZIL-PlsbB-lsbA, pAZIL-PlsbB-lsbX, pAZIL-PlsbB-lsbY,
AZIL-PlsbB-lsbZ, pAZIL-PlsbB-lsbXY and pAZIL-bN. The resulting
ransformants were screened on solid GM17 medium supple-
ented with 80 g/mL X-gal.
.7. Enzymatic activity-ˇ-galactosidase assay
-galactosidase activity was determined essentially as
escribed by Miller (1972) with the following modification. The
esulting derivatives initially screened on GM17 agar plates supple-
ented with X-gal and controls (MG7284/pNZ8150-PlsbB-lacZ1
nd MG7284/pNZ8150-lacZ1) were analyzed. Enzyme activity
as quantified in L. lactis in the exponential phase (OD600 = 1) of
rowth. One milliliter of cultures was harvested, and the pellet
as resuspended in 500 L of PP buffer with lysozyme (4 mg/mL).
he reaction mixture was incubated for 30 min  in a water bath at
7 ◦C. Bacterial cells were harvested by centrifugation at 5000 × g
nd resuspended in 500 L of Z buffer (60 mM Na2HPO4·7H2O,
0 mM NaH2PO4·H2O, 10 mM KCl, 1 mM MgSO4·7H2O, 50 mM
-mercaptoethanol). Twenty microliters of chloroform and 20 L
f 0.1% sodium dodecyl sulfate (SDS) were added to the mixture
nd it was vortexed for 20 s. After 5 min  of incubation at room
emperature, 200 L of ONPG (4 mg/mL) was added. After the
ppearance of yellow color the reaction was stopped by the addingof 250 L of 1 M sodium carbonate. After centrifugation, A420 value
was measured for the supernatant. -galactosidase activity in
Miller units was calculated as (1000·A420)/(t·v·OD600) where “t” is
time in minutes, “v” is the volume of culture used in the assay in
milliliters and OD600 is the optical density of the culture at 600 nm.
2.8. RT-PCR
Total mRNA was  isolated from lactococcal derivatives
MG7284/pAZIL-lsbB and MG7284/pAZIL-ES. For DNAse treat-
ment a DNA-freeTM Kit (Ambion, Life technologies, USA) was
used. The quantity and purity of mRNA were checked on a 1.2%
formaldehyde-agarose gel (FA gel). First strand cDNA synthesis
with reverse transcriptase was carried out with Thermo Scientific
RevertAid Reverse Transcriptase. The mRNA (2.5 g) was reverse
transcribed with 50 ng of Thermo Scientific Random hexamers.
The obtained cDNA was subsequently amplified by PCR using
appropriate pairs of primers (Table 2). The size of the obtained PCR
products was checked on a 1% agarose gel.
2.9. Measurements of mRNA degradation
Actinomycin D was used as a transcription inhibitor to enable
the measurement of the stability of mRNA in L. lactis subsp. cre-
moris derivatives MG7284/pAZIL-lsbB and MG784/pAZIL-ES. When
used, the actinomycin D (Serva, GmbH, Deisenhofen, Germany)mid-log phase (OD600 = 0.5) before actinomycin D was  added, and
reactions were stopped after 10 and 30 min  mRNA was  isolated as
described above, and samples were diluted in nuclease-free water
to a standard concentration of total RNA (1 g/mL).
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is  subsp. cremoris MG7284 pAZIL-lsbB with wild type strain L. lactis subsp. lactis
GMN1-596T (2). L. lactis subsp. lactis BGMN1-596 was used as an indicator strain.
lates were incubated overnight at 30 ◦C for development of inhibition zones.
.10. qRT-PCR
mRNA purified from derivatives MG7284/pAZIL-ES and
G7284/pAZIL-lsbB was quantified with real-time quantitative
CR (qRT-PCR) using a SYBR Green ER kit (Life technologies, Carls-
ad, CA) in a thermocycler (7500 Real Time PCR System) using pairs
f primers (rpoBsalcodF and rpoBsalcodR; RLsbBA30STOP and RT4)
o amplify the genes of interest, rpoB and lsbB (Table 2). qRT-PCRs
ere carried out according to the manufacturers protocol using
0 ng total RNA per 20 L of reaction mixture unless otherwise
pecified. The absence of contaminating DNA was  confirmed by
erforming PCR in the absence of reverse transcriptase (efficiencies
anged from 99.0%).
. Results and discussion
Synthesis of LsbB bacteriocin is plasmid encoded. Previously,
t was reported that a derivative L. lactis subsp. lactis BGMN1-
96T contains plasmid pMN5 carrying the structural bacteriocin
ene lsbB (Gajic et al. 2003; Kojic et al. 2006). The LmrB protein,
ocated upstream of the lsbB gene, transcribed in the opposite
rientation, is involved in bacteriocin transport and immunity.
on-lantibiotics, the genetic determinants of which have been
roposed to confer immunity, are frequently found in the bac-
eriocin operons, often located downstream of the bacteriocin
tructural genes (Klaenhammer 1993). In previous experiments
t was observed that derivative MG7284/pAZIL-lsbB expresses a
ignificantly lower zone of inhibition than the strain BGMN1-
96T (Fig. 1; Uzelac et al. 2013). Considering that the construct
AZIL-lsbB carries lsbB cloned with promoter PlsbB, we analyzed
he influence on LsbB production of lsbB surrounding genes and
equences located on plasmid pMN5. The reason for a larger zone
f inhibition for the strain carrying pMN5 could be due to another
acteriocin production that is plasmid encoded. To test this pos-
ibility the following experiments were completed: (a) deletion of
ifferent parts of pMN5 and knock-out of ORFs, and (b) cloning and
xpression of each ORF present on pMN5 in the pAZIL vector alone.
ecause plasmid pMN5 is a natural lactococcal plasmid, which is
nsuitable for manipulation and gene knock-out experiments, we
repared construct pAZIL-EX (EcoRI-XmnI, 2821 bp) which showed
hat it contains all of the required genes to regulate LsbB bacterio-
in expression; expressing the same size of inhibition zone as theesearch 179 (2015) 45–53 49
strain carrying pMN5. L. lactis subsp. cremoris MG7284 is a natu-
rally resistant strain to LsbB and was  successfully transformed with
the construct pAZIL-EX, giving the derivative MG7284/pAZIL-EX
which produces the same size of inhibition zone as strain BGMN1-
596T (7 mm)  on sensitive strain BGMN1-596. This construct was
used for further gene knock-out experiments. Gene knock-out of
lsbB, lmrB and lmrB/lsbB, resulted in the constructs pAZIL-bN (with
its NcoI restriction site blunted by incorporating four nucleotides
by Klenow enzyme, inducing changes to amino acids after 25 in
LsbB), pAZIL-SS  and pAZIL-NSS, respectively (for details see
Section 2 and Fig. 2). Three lactococcal strains, MG7284, IL1403 and
BGMN1-596 were transformed with all constructs and the obtained
transformants were used as bacteriocin producers in an agar well
diffusion assay. The results show that the lsbB gene knock-out car-
riers MG7284/pAZIL-bN and IL1403/pAZIL-bN, as with lsbB/lmrB
deletants MG7284/pAZIL-NSS and IL1403/pAZIL-NSS, have no
bacteriocin activity against the sensitive strain BGMN1-596. In
both constructs lsbB is knocked-out, and the absence of this
gene leads to the absence of antimicrobial activity. The transfor-
mant MG7284/pAZIL-SS with knocked-out lmrB gene showed
bacteriocin activity as the primary strain BGMN1-596T. Trans-
formants of IL1403 and BGMN1-596 were not obtained, as we
expected, with constructs lacking the lmrB gene because IL1403
and BGMN1-596 do not possess the lmrB or lmrP genes which code
for proteins necessary for immunity to LsbB bacteriocin, unlike
MG7284, which expresses LmrP (Bolotin et al. 2001). These results
strongly indicate that strain BGMN1-596T (a carrier of plasmid
pMN5) produces only LsbB bacteriocin, and the different sizes of
antimicrobial zones between derivatives MG7284/pAZIL-lsbB and
BGMN1-596T is due to other factors. In addition a new construct
was made, pAZIL-ES (containing only 736 bp EcoRI-ScaI  frag-
ment of pMN5), and the bacteriocin activity of obtained MG7284
transformants (MG7284/pAZIL-ES) were tested. Because the con-
structs MG7284/pAZIL-ES showed the same antimicrobial activity
as MG7284/pAZIL-EX and MN1-596T it was  concluded that for full
expression of lsbB it is a sufficient EcoRI-ScaI  sequence. Four poten-
tial genes downstream of the lsbB gene on the EcoRI-ScaI  fragment
were defined (lsbA, lsbX, lsbY, lsbZ; Fig. 2) as potential candidates
for regulators responsible for increased activity. Because bioinfor-
matics analysis showed that none of the defined genes have their
own promoter, all of them were cloned downstream of promoter
PlsbB. PlsbB promoter was  first cloned in the pAZIL vector as an
EcoRI-BamHI fragment by the incorporation of restriction sites into
primers for amplification, and after that additionally amplified frag-
ments carrying lsbA, lsbX, lsbY or lsbZ individually or combined into
a group of two  (lsbX-lsbY) were cloned downstream of the PlsbB
promoter as BamHI-PstI  fragments. The resulting constructs were
transferred into L. lactis MG7284 and the bacteriocin production of
the transformants was tested. None of the obtained transformants
showed bacteriocin activity no matter what construct was used for
transformation, demonstrating that not one of the cloned genes
(lsbA, lsbX, lsbY, lsbZ or lsbX-lsbY) encodes for bacteriocin or that
the greater inhibition zone is not a result of the synergistic effect of
LsbB and another bacteriocin. In addition the best bacteriocin can-
didate, LsbA was  chemically synthesized (ChinaPeptides Co., Ltd.),
but it did not show any antibacterial activity against BGMN1-596.
The second possible explanation for the defined genes’ influence
on the bacteriocin activity of LsbB is if they were part of two-
component bacteriocins (LsbB representing one component, which
alone has bacteriocinogenic activity). It is known that components
of two  (or more) component bacteriocins can sometimes have bac-
teriocin activity alone, while together having or increasing activity
(Oppegard et al. 2007; Cooper et al. 2008; Hu et al. 2010; Coelho
et al. 2014). In order to test this hypothesis all of the cloned genes
were co-expressed in-trans with the gene lsbB. For that purpose
lsbB, with its own promoter was transferred as a SacI-PstI fragment











ig. 2. Linear gene map of the EcoRI-XmnI region of pMN5 plasmid carrying the lsb
or  analysis of influence of different genes/regions on the expression of the lsbB gen
ndicated by arrows.
rom pAZIL (erythromycin resistance) to the pNZ8150 vector
chloramphenicol resistance), giving the pNZ8150-lsbB construct.
train MG7284 was first transformed with pNZ8150-lsbB and after
hat additionally transformed with pAZIL constructs carrying the
ther genes, lsbA, lsbX, lsbY, lsbZ or lsbX-lsbY, under PlsbB. Again
ot one pAZIL construct increased production of LsbB in-trans
ompared to the control carrying only pNZ8150-lsbB. From theseron and the scheme of construction knock-out mutants, deletants and clones used
evant restriction sites are indicated. The size and orientation of predicted ORFs are
results we conclude that the other genes present on plasmid pMN5
are not part of a two-component bacteriocin and that they are not
involved in LsbB overexpression in the strain BGMN1-596T.In parallel, the level of PlsbB promoter transcription was
measured using the newly constructed promoter fusion vec-
tor pNZ8150-lacZ1 (Vukotic et al. 2015) in order to test the
in-trans influence of the labA, lsbX, lsbY, lsbXY and lsbZ genes

































































Fig. 3. Agar plate inhibition assay for measuring the level of LsbB expression by the
WT  strain L. lactis subsp. lactis BGMN1-596T (BGMN1-596T) and different clones
in  L. lactis subsp. cremoris MG7284: pAZIL-lsbB (MG7284/pAZIL-lsbB), pAZIL-EX
(MG7284/pAZIL-EX) and pAZIL-lsbBlsbX3 (MG7284/pAZIL-lsbBlsbX3). Known con-
centrations of synthetic LsbB, as standards, were used for quantification of LsbB
production (LsbB synthetic). Numbers on Petri dishes indicate dilution ratio (for
LsbB producers) and concentrations of LsbB (from 1 mg  to 3.75 g; for synthetic
LsbB). Solidified GM17 top agar containing L. lactis subsp. lactis BGMN1-596 as anG. Uzelac et al. / Microbiolo
n PlsbB promoter activity. The initial derivative carrying the
lsbB promoter fusion MG7284/pNZ8150-PlsbB-lacZ1 was used for
urther transformation with constructs pAZIL-PlsbB-lsbA, pAZIL-
lsbB-lsbX, pAZIL-PlsbB-lsbY, pAZIL-PlsbB-lsbXY, pAZIL-bN and
AZIL-PlsbB-lsbZ. The obtained CmR, EmR transformants were
sed for measurements of -galactosidase activity, where it was
hown that none of the derivatives have a significant influence
n -galactosidase activity compared to the control derivative
G7284/pNZ8150-PlsbB-lacZ1. The difference in activity between
he control strain and derivatives did not have statistical signifi-
ance (P < 0.5). From the results of promoter activity it is possible
o conclude that increased LsbB bacteriocin production in BGMN1-
96T is not the result of increased promoter activity or transcription
overned by any of tested genes; none of genes are transcription
egulators, pheromones or quorum-sensing peptides.
Because none of the analyzed elements were able to increase
xpression of lsbB in-trans, further experiments focused on testing
he in-cis influence of the various elements. The cis-acting elements
hat could stabilize mRNA from degradation are stable stem-loops
t the 5′ end of the transcript and terminators or REP sequences at
heir 3′ end (Grunberg-Manago 1999).
Considering that construct pAZIL-ES (EcoRI-ScaI, 736 bp) that
rovides full expression of LsbB bacteriocin as BGMN1-596T pos-
esses the same 5′ region as pAZIL-lsbB, it was concluded that
ncreased activity could be attributed to the 3′ region of the clone.
o test this assumption, deletion of the 3′ region of the construct
as performed, and further constructs were made: pAZIL-lsbBlsbX
nd pAZIL-lsbBlsbXY, which were shorter than pAZIL-ES. After
esting the activity of the constructs in strain MG7284 it was
ealized that both express full bacteriocin activity, showing that
he region responsible for enhanced expression of LsbB is located
ithin gene lsbX. In order to test for possible involvement of
sbX in-cis or as a protein, additional constructs were prepared
nd expressed in MG7284: pAZIL-lsbBlsbX (with full lsbX), pAZIL-
sbBlsbX1 (with deletion of the last five nucleotides of lsbX),
AZIL-lsbBlsbX2 (with deletion of the last 12 nucleotides of lsbX),
AZIL-lsbBlsbX3 (with deletion of the last 22 nucleotides of lsbX),
AZIL-lsbBlsbX4 (with deletion of the last 38 nucleotides of lsbX)
nd pAZIL-lsbBlsbXSt (containing full length lsbX with stop codon
nserted in the middle). In an agar well diffusion assay, transfor-
ants carrying construct pAZIL-lsbBlsbX4 showed smaller zones of
nhibition like those carrying pAZIL-lsbB, while all others expressed
he same inhibition zone as BGMN1-596T, MG7284/pAZIL-EX and
G7284/pAZIL-ES. From the results of bacteriocin activity tests we
an conclude that regulation of LsbB expression is maintained by
NA structure; no one ORF is involved. Computer analysis of the
equence of 53 nucleotides downstream of lsbB (using the short-
st construct that gave full bacteriocin activity, pAZIL-lsbBlsbX3)
Macke et al. 2001) showed the presence of a transcription
erminator (CTATTAAGGAAAAACTGCAACAATAGTTGCAGTTTTTAT-
ATGCATA), which finishes five nucleotides before the end of
lone pAZIL-lsbBlsbX3. The presence of this transcription ter-
inator, we can assume, has an influence on the stability of
RNA, which is important for full expression of lsbB in L. lac-
is BGMN1-596T. As RNA stability is an important component of
ene expression, we measured the mRNA decay patterns for genes
ncoding RNA polymerase subunit rpoB and structural bacteriocin
ene lsbB. The results showed greater mRNA stability in derivative
G7284/pAZIL-ES, which contains the transcription terminator,
han in MG7284/pAZIL-lsbB without the transcription terminator
egion. We  also compared the secondary structures of these two
ranscripts, which differ by only 21 nucleotides, using ViennaRNAeb  Services (rna.tbi.univie.ac.at) and found that the secondary
NA structure of the transcript that contains the transcription ter-
inator has a free energy value of −46.20 kcal/mol, in contrast to
36.30 kcal/mol for the shorter one. Data related to the regulationindicator strain were spotted with 5 L of filtered supernatants or synthetic LsbB.
Plates were incubated overnight at 30 ◦C for development of inhibition zones.
of gene expression by transcription terminators are limited (Klug
1993; Ciampi 2006; Peters et al. 2009; Caballero et al. 2012; Czyz
et al. 2014; Shashni et al. 2014) and none are related to lactic acid
bacteria. It is interesting that the presence of a complete transcrip-
tion terminator sequence in the transcript increased RNA stability
by three times, while double dilution bacteriocin assay resulted in
the expression of LsbB being increased by 30 times (Fig. 3). In addi-
tion, comparing the expression of LsbB of two constructs carrying
the lsbB gene, one containing half of the transcription termina-
tor sequence (pAZIL-lsbB) and the other with only the first four
nucleotides (pAZIL-lsbBEV) and we  conclude that because we were
not able to detect any differences in production of LsbB between
them, and together with results obtained by other deletion exper-
iments, for full expression of LsbB the presence of a complete
transcription terminator sequence is necessary. It may be that other
factors are involved in this enhanced expression of LsbB, but this
will be a subject for further investigation.
From our current results we are able to conclude that the expres-
sion of bacteriocin LsbB in L. lactis subsp. lactis BGMN1-5 is driven
by a sequence located immediately downstream of the lsbB gene
carrying only a transcription terminator (transcription termina-
tor sequence start one nucleotide after stop codon of gene lsbB).
This has for the first time demonstrated that a transcription ter-
minator sequence can strongly influence bacteriocin expression. A
similar increment (more than 10 times) of gene expression depend-
ent on the transcription terminator was obtained for the gluQ-rs
gene in Shigella flexneri (Caballero et al. 2012). The effect of the
lsbB transcription terminator sequence on other genes of interest
was tested in order to determine whether this sequence could be
used to enhance their expression. For that experiment the lcnB gene
(for expression of lactococcin B, another class II bactriocin) was
cloned immediately upstream of the transcription terminator in
the pAZIL vector. First, the transcription terminator was  cloned as a
HindIII-EcoRI fragment from construct pAZIL-lsbBlsbX3 into pBlue-
script predigested with the same enzymes giving the construct
pBSTT. After that the amplified lcnB gene with its own promoter
using primers LcnBF and LcnBR (Table 2) was re-cloned from pBlue-
scriptT/A into pBSTT as the SalI-ClaI fragment giving the pBSLcnBTT
construct. Finally, two constructs were obtained: pAZIL-LcnB carry-
ing the lcnB gene with its own promoter and pAZIL-LcnBTT carrying
52 G. Uzelac et al. / Microbiological R
Fig. 4. (A) Agar plate inhibition assay for measuring the level of LcnB expression
by  different clones in L. lactis subsp. lactis B464: pAZIL-lcnB (B464/pAZIL-lcnB), and
pAZIL-lcnBTT (B464/pAZIL-lcnBTT) and (B) schematic presentation of constructs.
Numbers on Petri dish indicate dilution ratio (forLsbB and LcnB producers). Num-
bers on the Petri dishes indicate the dilution ratio (forLsbB and LcnB producers).
Solidified GM17 top agar containing L. lactis subsp. lactis BGMN1-596 as indica-
tor  strain was  spotted with 5 L of filtered supernatants of producers. Plates were
incubated overnight at 30 ◦C for development of inhibition zones. 1. L. lactis subsp.


























signaling in bacteria. Washington, DC: American Society for Microbiology; 1999.464/pAZIL-lcnBTT; 4. L. lactis subsp. lactis B464/pAZIL-lcnB. Relevant restriction
ites are indicated. The size and orientation of predicted ORFs are indicated by
rrows.
he lcnB gene with its own promoter and transcriptional terminator
ocated immediately downstream. Bacteriocin activity of trans-
ormants of B464 (L. lactis subsp. lactis IL1403 mutant resistant
o LcnB; Diep et al. 2007) carrying one of these two  constructs
as compared. It was observed that the bacteriocin activity of
ransformants carrying the transcription terminator was higher (at
east two times, Fig. 4), but not as high as for LsbB. This result
emonstrates the importance of this transcription terminator in
acteriocin expression and that it can act also on heterologous
enes, but not as strongly as for lsbB classifying it as being more
ene specific.
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